問題詳情
73. 有關於 phosphodiesterase-4 (PDE4) inhibitors 的藥物用於 COPD 治療，下列何者為非：
(A) By its mechanism, PDE4 inhibitors decrease airway inflammation and have direct bronchodilator activity.
(B) PDE4 inhibitors has been approved for patients with chronic bronchitis and a history of exacerbation
(C) Guidelines recommend that PDE4 inhibitors be used in combination with a long-acting bronchodilators
(D) Monitoring weight during treatment is warranted.
參考答案
答案：A
難度：計算中-1
書單：沒有書單，新增